Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy.

Conclusions: SBRT for CWI NSCLC is safe, with high early tumor control and low treatment-related toxicity. Most patients with pre-treatment chest wall pain experienced relief after SBRT, with no grade 3+ toxicity observed.
PMID: 30859139 [PubMed]

Source: Clinical Lung Cancer - March 13, 2019 Category: Cancer & Oncology Authors: Kennedy WR, Gabani P, Nikitas J, Samson PP, Robinson CG, Bradley JD, Roach MC Tags: Clin Transl Radiat Oncol Source Type: research